|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
5R01CA186338-03
|
$342,938
|
$342,938
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
|
1R01CA220236-01
|
$366,000
|
$366,000
|
XIE, KEPING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$10,856
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$100,976
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$2,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$4,083
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
$65,844
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-02
|
$2,143,077
|
$2,143,077
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
Washington University PDX Development and Trial Center
|
1U54CA224083-01
|
$2,424,750
|
$945,653
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-02
|
$176,231
|
$176,231
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
$29,612
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of pancreatic cancer biomarkers in large prospective cohorts
|
5R01CA196286-03
|
$417,779
|
$417,779
|
LOKSHIN, ANNA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
3U01CA200466-02S1
|
$129,694
|
$129,694
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-02
|
$1,537,769
|
$1,537,769
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-06
|
$646,350
|
$646,350
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$625
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$8,750
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$8,604
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-02
|
$953,081
|
$953,081
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Using Markers to Improve Pancreatic Cancer Screening
|
5R01CA176828-05
|
$416,661
|
$416,661
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
$1,200
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$125,270
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
University of Virginia Cancer Center Support Grant
|
2P30CA044579-26
|
$2,574,504
|
$154,470
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S1
|
$125,000
|
$7,500
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S2
|
$104,087
|
$6,245
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Texas PDX Development and Trial Center
|
1U54CA224065-01
|
$2,561,686
|
$230,552
|
ROTH, JACK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$616,604
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
$5,000
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
$3,097
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Colorado Cancer Center Support Grant
|
2P30CA046934-29
|
$3,880,607
|
$116,418
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-29S1
|
$3,780
|
$113
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-29S2
|
$104,106
|
$3,123
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-37S1
|
$75,000
|
$3,750
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
5P30CA023074-37
|
$3,533,423
|
$176,671
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
Understanding optimal delivery systems for cancer care
|
5R01CA174768-04
|
$377,699
|
$94,425
|
MILLER, DAVID
|
UNIVERSITY OF MICHIGAN
|
|
Understanding metabolic pathways that support redox homeostasis in cancer
|
1F32CA213810-01
|
$56,694
|
$56,694
|
MUIR, ALEXANDER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell
|
3F32CA210421-01S1
|
$2,212
|
$1,106
|
DANAI, LAURA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell
|
5F32CA210421-02
|
$56,694
|
$28,347
|
DANAI, LAURA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
|
1R01CA204969-01A1
|
$332,357
|
$332,357
|
NAGRATH, DEEPAK
|
UNIVERSITY OF MICHIGAN
|
|
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer
|
2R01CA154451-04A1
|
$498,703
|
$498,703
|
HWANG, JOO
|
UNIVERSITY OF WASHINGTON
|
|
Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone
|
1R44CA224994-01
|
$224,791
|
$112,396
|
NEDERLOF, MICHEL
|
QUANTITATIVE IMAGING SYSTEMS, LLC
|
|
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
|
5U01CA198846-03
|
$476,683
|
$476,683
|
NEL, ANDRE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-04
|
$592,771
|
$29,639
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
|
5F31CA196329-02
|
$31,376
|
$31,376
|
NASCIMENTO, ALDO
|
UNIVERSITY OF VIRGINIA
|
|
Tumor subtypes and therapy response in pancreatic cancer
|
5R01CA199064-02
|
$600,010
|
$600,010
|
YEH, JEN JEN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
|
5R01CA198096-03
|
$429,377
|
$429,377
|
STRAUBINGER, ROBERT
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$9,496
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
|
5P01CA067166-20
|
$1,585,768
|
$428,157
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
Total relevant funding to Pancreas for this search: $178,331,745
|